VKTX

Viking Therapeutics Inc

Jun 23 • 04:00PM ET

34.81

+2.44 7.54 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: MDGL AXSM ACAD KROS KYMR RYTM BMRN NUVL INCY NBIX

| Held by: VTI XBI VB VBK VXF SCHA IWR VHT DFMC IWD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.15	Insider Own	2.83%	Shs Outstand	115.89M	Perf Week	17.48%
Market Cap	4.04B	Forward P/E	-	EPS next Y	-4.77	Insider Trans	-9.88%	Shs Float	112.82M	Perf Month	13.46%
Enterprise Value	3.44B	PEG	-	EPS next Q	-1.23	Inst Own	63.41%	Short Float	19.83%	Perf Quarter	6.94%
Income	-472.33M	P/S	-	EPS this Y	-48.95%	Inst Trans	0.34%	Short Ratio	10.18	Perf Half Y	2.53%
Sales	0.00M	P/B	8.04	EPS next Y	-0.37%	ROA	-64.04%	Short Interest	22.37M	Perf YTD	-1.05%
Book/sh	4.33	P/C	6.70	EPS next 5Y	-7.01%	ROE	-70.04%	52W High	43.15 -19.33%	Perf Year	40.02%
Cash/sh	5.19	P/FCF	-	EPS past 3/5Y	-52.71% -42.46%	ROIC	-94.11%	52W Low	22.96 51.62%	Perf 3Y	70.64%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.15% 4.91%	Perf 5Y	469.72%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-259.98%	Oper. Margin	-	ATR (14)	1.68	Perf 10Y	2730.08%
Dividend Ex-Date	-	Quick Ratio	5.72	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	68.29	Recom	1.21
Dividend Gr. 3/5Y	- -	Current Ratio	5.72	EPS Q/Q	-236.44%	SMA20	14.84%	Beta	0.69	Target Price	94.29
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	10.65%	Rel Volume	2.83	Prev Close	32.37
Employees	53	LT Debt/Eq	0.00	Earnings	Apr 29 AMC	SMA200	7.16%	Avg Volume	2.20M	Price	34.81
IPO	Apr 29, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-40.43% -	Trades		Volume	6,212,698	Change	7.54%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)